Jaydira Del Rivero, M.D.

Jaydira Del Rivero, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Developmental Therapeutics Branch


Dr. Del Rivero is a Physician Scientist in the Developmental Therapeutics Branch. She is the Principal Investigator of the Natural History Study for Neuroendocrine Neoplasm and Adrenocortical Cancer to provide the basis of further development of therapeutic interventions, prevention/screening guidelines, endpoints for future clinical trials, and patient reported outcome measures. Dr. Del Rivero’s current efforts is the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroenteropancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma. 

Areas of Expertise

Neuroendocrine Neoplasms
Neuroendocrine Tumors
Neuroendocrine Carcinomas
Adrenocortical Carcinoma

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

Clinical Trials


Selected Key Publications

A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules

Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue , Claudia Palena, Jaydira Del Rivero, Jason M Redman, Ravi A Madan, Jennifer L Marté, Lisa M Cordes, Elizabeth Lamping, Alanvin Orpia, Andrea Burmeister, Eva Wagner, Cesar Pico Navarro, Christopher R Heery, Jeffrey Schlom , James L Gulley
Clin Cancer Res. 2019. [ Journal Article ]

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer

Jaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A Madan, Sanjeeve Balasubramaniam, Tito Fojo, Ann W Gramza
2019. [ Journal Article ]

Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors

Alex M Rosenberg, Patricia Friedmann, Jaydira Del Rivero, Steven K Libutti, Amanda M Laird
Surgery. 2016. [ Journal Article ]

Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence

Aman Chauhan , Elise Kohn , Jaydira Del Rivero
JAMA Oncology. 2019. [ Journal Article ]

PARP Inhibitors: The Cornerstone of DNA Repair-Targeted Therapies

Del Rivero J and Kohn EC.
Oncology. 31(4): 265-73, 2017. [ Journal Article ]


A Destiny in Neuroendocrine Oncology

The NIH Catalyst
January-February 2021

Jaydira del Rivero is one of the world’s few specialists in rare cancers that originate in the body’s neuroendocrine system, which is made up of specialized cells that make hormones in response to neurological signals. Her goal is to treat these tumors holistically—using a biological approach as well as taking the whole patient into consideration. Read more...

Patient Education Day

August 15, 2020

Dr. Del Rivero participated in the Society of Nuclear Medicine & Molecular Imaging's Annual Patient Education Day.  She was a speaker in a webinar about neuroendocrine tumors.  Learn more…